Hossein Jamali, Mohammad Hassan Jalalpour*, Mohammad Reza Badie and Maryam Nadi

Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

*Corresponding Author: Mohammad Hassan Jalalpour, Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Received: July 24, 2023; Published: September 28, 2023

Abstract

Purpose: Pellucid marginal degeneration (PMD) is a rare non-inflammatory corneal ectasia that progresses, making visual rehabilitation challenging. Since PMD is unique and different from keratoconus, the effect of collagen cross-linking might be different. This study aims to evaluate the efficacy of accelerated corneal collagen crosslinking (CXL) over a 5-year follow-up period in patients with PMD.

Methods: A retrospective interventional case series study was conducted on 43 eyes of 24 patients with PMD who underwent accelerated CXL. Visual acuity, refraction, topographic keratometry, pachymetry, and topometric indices were measured before and after the procedure.

Results: The study found an improvement in visual acuity from LogMAR 0.36 ± 0.22 before CXL to LogMAR 0.21 ± 0.12 after CXL (P < 0.001). The study also observed a reduction in the sphere from -2.46 ± 1.81 D before CXL to -1.7 ± 1.63 after CXL (P < 0.001). However, there was no significant difference in cylindrical value (P = 0.83). Flat keratometry decreased from 45.11 ± 1.75 D preoperatively to 44.30 ± 1.75 postoperatively (P < 0.001), but steep keratometry did not change significantly (preoperative 47.92 ± 1.74D, postoperative 47.53 ± 1.70, P = 0.081). Additionally, maximum keratometry reduced from 51.03 ± 3.21 D before CXL to 50.53 ± 3.42 after CXL (P = 0.005).

Conclusions: The results of this study suggest that accelerated CXL can be effective in treating PMD, as it was found to improve visual acuity and reduce spherical and maximum keratometry values.

Keywords: Collagen Cross-linking; Pellucid Marginal Degeneration; Keratoconus; Penetrating Keratoplasty; Deep Anterior Lamellar Keratoplasty

References

1. Krachmer JHJAoO. “Pellucid marginal corneal degeneration”. Archives of Ophthalmology7 (1978): 1217-1221.
2. Belin MW., et al. “What's in a name: keratoconus, pellucid marginal degeneration, and related thinning disorders”. American Journal of Ophthalmology2 (2011): 157-162.e1.
3. Walker RN., et al. “Scheimpflug photographic diagnosis of pellucid marginal degeneration”. Cornea 8 (2008): 963-966.
4. Schlaeppi VJPAO. “La dystrophie marginale inferieure pellucide della cornee”. Probl Actuels Ophthalmol 1 (1957): 672-677.
5. Sridhar M., et al. “Pellucid marginal corneal degeneration”. Journal of Ophthalmology 6 (2004): 1102-1107.
6. Dundar H., et al. “Unilateral superior pellucid marginal degeneration in a case with ichthyosis”. Contact Lens and Anterior Eye 1 (2011): 45-48.
7. Puy P., et al. “Temporal pellucid marginal degeneration displaying high “with-the-rule” astigmatism”. Canadian Journal of Ophthalmology6 (2013): e142-e4.
8. Lee BW., et al. “Ecstatic disorders associated with a claw-shaped pattern on corneal topography”. American Journal of Ophthalmology1 (2007): 154-156.e3.
9. Karabatsas C and Cook SJE. “Topographic analysis in pellucid marginal corneal degeneration and keratoglobus”. Eye4 (1996): 451-455.
10. Tummanapalli SS., et al. “Evaluation of corneal elevation and thickness indices in pellucid marginal degeneration and keratoconus”. Journal of Cataract and Refractive Surgery1 (2013): 56-65.
11. Martínez-Abad A., et al. “Pellucid marginal degeneration: Detection, discrimination from other corneal ectatic disorders and progression”. Contact Lens and Anterior Eye4 (2019): 341-349.
12. Krachmer JH., et al. “Keratoconus and related noninflammatory corneal thinning disorders”. Survey of Ophthalmology4 (1984): 293-322.
13. Sridhar M., et al. “Superior pellucid marginal corneal degeneration”. Eye4 (2004): 393-399.
14. Imbornoni LM., et al. “Evolution of keratoconus: from diagnosis to therapeutics”. Klinische Monatsblätter für Augenheilkunde6 (2018): 680-688.
15. Klyce SDJIo and Science v. “Computer-assisted corneal topography. High-resolution graphic presentation and analysis of keratoscopy”. Investigative Ophthalmology12 (1984): 1426-1435.
16. Rabinowitz YS and McDonnell PJJJoRS. “Computer-assisted corneal topography in keratoconus”. Journal of Refractive Surgery (1989): 400-408.
17. Rabinowitz YSJJoRS. “Videokeratographic indices to aid in screening for keratoconus”. Journal of Refractive Surgery (1995): 371-406.
18. Al-Torbak AAJSJoO. “Deep anterior lamellar keratoplasty for pellucid marginal degeneration”. Saudi Journal of Ophthalmology1 (2013): 11-14.
19. Moshirfar M., et al. “Current options in the management of pellucid marginal degeneration”. Journal of Refractive Surgery7 (2014): 474-485.
20. Wittig-Silva C., et al. “A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results”. Journal of Refractive Surgery7 (2008): S720.
21. Irajpour M., et al. “Corneal cross-linking in pellucid marginal degeneration: Evaluation after five years”. Journal of Current Ophthalmology2 (2022): 229.
22. Pircher N., et al. “Corneal crosslinking for pellucid marginal degeneration”. Journal of Cataract and Refractive Surgery8 (2019): 1163-1167.
23. Steppat M., et al. “Collagen cross-linking in patients with pellucid marginal corneal degeneration (PMD)”. Investigative Ophthalmology and Visual Science13 (2008): 4342.
24. Brittingham S., et al. “Corneal cross-linking in keratoconus using the standard and rapid treatment protocol: differences in demarcation line and 12-month outcomes”. Investigative Ophthalmology 12 (2014): 8371-8376.
25. Bikbov M., et al. “Results of corneal crosslinking for pellucid marginal corneal degeneration”. Vestnik oftalmologii3 (2017): 58-66.
26. El-Massry AA-K., et al. “Evaluation of the effect of corneal collagen cross-linking for keratoconus on the ocular higher-order aberrations”. Clinical Ophthalmology 11 (2017): 1461.
27. Stojanovic A., et al. “Topography-guided transepithelial surface ablation followed by corneal collagen cross-linking performed in a single combined procedure”. Journal of Refractive Surgery2 (2010): 145-152.
28. Kymionis GD., et al. “Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking”. Journal of Cataract and Refractive Surgery7 (2009): 1298-1301.
29. Cagil N., et al. “Transepithelial phototherapeutic keratectomy followed by corneal collagen cross-linking for treating pellucid marginal degeneration: Long-term Results”. Cornea8 (2019): 980-985.

Citation

Citation: Mohammad Hassan Jalalpour., et al. “Long-Term Follow-Up of the Effect of Accelerated CXL Protocol on Pellucid Marginal Degeneration".Acta Scientific Ophthalmology 6.10 (2023): 34-38.

Copyright

Copyright: © 2023 Mohammad Hassan Jalalpour., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.